Week 2 Discussion Post: Virginia APRN Prescriptive Authority and Collaborative Practice

Course Context

This discussion post forms part of the Advanced Pharmacotherapeutics and Prescriptive Authority module within the Graduate Nursing program. The assignment assesses your ability to analyze state-specific nurse practice regulations, evaluate collaborative care models, and apply evidence-based reasoning to scope-of-practice debates that directly impact clinical decision-making.

Assignment Overview

In this forum, you will examine the Virginia Nurse Practice Act (NPA) and associated regulations governing prescribing by advanced practice registered nurses (APRNs), including certified nurse practitioners (CNPs), certified registered nurse anesthetists (CRNAs), certified nurse-midwives (CNMs), and clinical nurse specialists (CNSs). You will analyze statutory requirements for collaborative agreements, prescriptive authority parameters, controlled substance scheduling, and interprofessional approaches to common clinical presentations such as dermatological conditions across the lifespan.

Weight: 10% of total course grade

Word Count: 500–750 words for initial post; 150–250 words per peer response

Format: APA 7th edition in-text citations and reference list

Due Date: Initial post by Day 3 (11:59 PM EST); peer responses by Day 7 (11:59 PM EST)

Learning Objectives

• Analyze Virginia Code provisions governing APRN licensure, collaborative practice agreements, and autonomous practice eligibility
• Evaluate the rationale for and against physician collaboration requirements in prescriptive authority
• Assess controlled substance prescribing parameters for Schedule II through VI medications under Virginia law
• Synthesize interprofessional collaborative approaches to dermatological assessment and management across pediatric, adult, and geriatric populations
• Defend clinical positions using peer-reviewed evidence, statutory text, and professional guidelines

Task Description

Locate your state’s nurse practice act and associated regulations governing prescribing by advanced practice nurses. For students practicing in or intending to practice in Virginia, address the following four prompts in your initial discussion post. Students in other jurisdictions should apply these same analytical frameworks to their respective state regulations.

Prompt 1: Collaborative Practice Agreements

Does the Virginia NPA require the APRN to maintain a collaborative practice agreement with a physician? Discuss whether you believe the NPA should or should not require such an agreement, and explain your position using evidence from statutory language, peer-reviewed literature, or comparative state analysis. Consider the 2024 amendments under HB 971, which reduced the transition-to-practice requirement from five years to three years (5,400+ clinical hours) for autonomous practice eligibility.

Prompt 2: Prescribing Agreements

Does the Virginia NPA require the APRN to have a specific prescribing agreement with a physician? Discuss whether you believe the NPA should or should not require a separate prescribing agreement, and justify your reasoning. Address how Virginia limits the number of collaborative agreements a single patient care team physician may enter into with nurse practitioners (maximum of six NPs, with exceptions for psychiatric-mental health NPs).

Prompt 3: Controlled Substance Prescriptive Authority

Does the Virginia NPA permit APRNs to prescribe all classes (schedules) of medications? Discuss whether you believe the NPA should or should not permit APRNs to prescribe all schedules of controlled substances, and explain why. Reference Virginia Code § 54.1-2957.01 and the requirement for a bona fide practitioner-patient relationship prior to prescribing Schedule II through VI substances.

Prompt 4: Collaborative Approaches to Rash Management

Describe collaborative approaches to treating rashes across the lifespan. Should the CNP treat common dermatological conditions without a collaborator or consultant? Support your statements with evidence from pharmacotherapeutics literature, dermatology guidelines, and scope-of-practice standards. Address pediatric considerations (e.g., diaper dermatitis, atopic eczema), adult presentations (e.g., contact dermatitis, tinea infections), and geriatric concerns (e.g., herpes zoster, drug eruptions).

Requirements

1. Initial Post: Compose a 500–750 word response that addresses all four prompts. Integrate at least two peer-reviewed sources published between 2018 and 2026, and cite the Virginia Code or Board of Nursing guidance documents at least once.
2. Peer Responses: Respond substantively to at least two classmates by Day 7. Each response should be 150–250 words, extend the discussion by adding new evidence or a contrasting perspective, and include at least one scholarly citation.
3. Citation Format: Use APA 7th edition for all references. In-text citations must include author(s) and year; direct quotes require page numbers. The reference list should appear at the end of your initial post.
4. Professional Tone: Write in formal academic English. Avoid colloquialisms, contractions, and unsupported opinion. Use hedging language where appropriate (e.g., “the evidence suggests,” “it appears that”).
5. Originality: All posts will be screened through plagiarism detection software. Paraphrase statutory language and source material; do not copy-paste lengthy excerpts.

Grading Rubric

Sample Response Excerpt

The following excerpt demonstrates the depth, tone, and citation density expected for this assignment. It is not a template to copy but a benchmark for analytical rigor.

Virginia’s Transition-to-Practice Framework and Autonomous Practice Eligibility

Virginia Code § 54.1-2957 establishes a reduced-practice model for nurse practitioners that requires a written or electronic practice agreement with a patient care team physician until the NP meets autonomous practice thresholds. The 2024 enactment of HB 971 reduced the clinical experience requirement from five years (9,000 hours) to three years (5,400 hours), a legislative shift that aligns Virginia more closely with national trends toward full practice authority while retaining structured oversight during early career development. This amendment reflects accumulating evidence that NPs provide safe, high-quality care equivalent to physician-provided care in primary care settings, as demonstrated by systematic reviews spanning over five decades of outcomes research. The requirement for a practice agreement during the transition period functions as a patient safety mechanism; it ensures that newly licensed NPs have access to physician consultation for complex cases while developing independent clinical judgment. However, the statutory limitation that a single physician may serve as a patient care team physician for no more than six NPs (with an exception for ten psychiatric-mental health NPs) creates workforce distribution challenges, particularly in rural localities where physician supply is already constrained. From a policy perspective, I support the transition-to-practice model but argue that three years remains conservative when compared to states such as Arizona or Wyoming that grant full practice authority at licensure. The evidence suggests that NPs educated at the doctoral or master’s level with population-specific certification possess the requisite pharmacotherapeutic knowledge to prescribe independently upon initial licensure, provided they practice within their scope and maintain continuing education in pharmacology. Virginia’s requirement for 30 contact hours of pharmacology education for prescriptive authority, while reasonable, should be supplemented with mandatory continuing education in controlled substance prescribing and opioid stewardship given the Commonwealth’s ongoing substance use disorder crisis.

Controlled Substance Prescribing and the Bona Fide Practitioner-Patient Relationship

Virginia law authorizes APRNs to prescribe Schedule II through VI controlled substances and devices, provided the prescribing aligns with a valid practice agreement or autonomous practice authorization and the APRN has established a bona fide practitioner-patient relationship. This statutory framework places Virginia among the majority of states that permit NP prescribing of Schedule II opioids and stimulants, though it falls short of the full practice authority model adopted by twenty-two states and the District of Columbia. The bona fide relationship requirement, which includes performing an appropriate examination, initiating interventions, and scheduling follow-up care, mirrors federal expectations for controlled substance prescribing and serves as a safeguard against pill-mill practices. In my view, the restriction of Schedule II prescribing to established patient relationships is clinically appropriate and ethically justified; however, the blanket requirement for physician collaboration in the early practice years may unnecessarily delay access to care for patients in underserved areas. Comparative data from the National Council of State Boards of Nursing indicate that states with full practice authority experience no increase in malpractice claims or disciplinary actions related to NP prescribing, which challenges the assumption that physician oversight enhances pharmacological safety. For the CNP managing common dermatological conditions such as atopic dermatitis in pediatric patients or tinea corporis in adults, the ability to prescribe mid-potency topical corticosteroids (Schedule VI) or oral antifungals (non-controlled) independently after the transition period supports efficient, patient-centered care without compromising safety.

Interprofessional Collaboration in Dermatological Care Across the Lifespan

Collaborative approaches to rash management should be structured around clinical complexity rather than arbitrary statutory requirements. For straightforward presentations such as diaper dermatitis in infants or contact dermatitis in adults, the CNP with appropriate training in dermatological assessment and pharmacotherapeutics can safely initiate treatment without mandatory physician consultation, provided follow-up is scheduled to evaluate treatment response. The American Academy of Dermatology guidelines for atopic dermatitis management emphasize patient education, barrier repair, and step-up therapy with topical corticosteroids or calcineurin inhibitors, interventions well within the CNP scope. Conversely, rashes with systemic features, ambiguous morphology, or resistance to first-line therapy warrant interprofessional consultation; examples include Stevens-Johnson syndrome, cutaneous manifestations of systemic lupus erythematosus, or drug eruptions in polypharmacy geriatric patients. In these scenarios, collaboration with dermatology, rheumatology, or clinical pharmacology specialists enhances diagnostic accuracy and therapeutic outcomes. The decision to treat independently or refer should therefore rest on the CNP’s assessment of their own competency, the patient’s clinical presentation, and the availability of specialist resources rather than on blanket statutory mandates. This approach respects the CNP’s professional autonomy while maintaining patient safety through evidence-based clinical reasoning and structured follow-up protocols.

References and Learning Materials

1. Arcangelo, V. P., Peterson, A. M., Wilbur, V., and Reinhold, J. A. (2017). Pharmacotherapeutics for advanced practice: A practical approach (4th ed.). Wolters Kluwer/Lippincott Williams and Wilkins.
2. American Association of Nurse Practitioners. (2020, October 20). State practice environment. https://www.aanp.org/advocacy/state/state-practice-environment
3. Buppert, C. (2017). Thoughts about drafting bills to give nurse practitioners full practice authority. The Journal for Nurse Practitioners, 13(7), 497–498. https://doi.org/10.1016/j.nurpra.2017.05.015
4. Commonwealth of Virginia, Department of Health Professions. (2024). Guidance Document 90-56: Practice agreement requirements for nurse practitioners. Virginia Board of Nursing. https://www.dhp.virginia.gov/Boards/Nursing/
5. National Council of State Boards of Nursing. (2025). 2025 Advanced practice registered nurse survey: Prescriptive authority. https://www.ncsbn.org/public-files/APRN_Survey_2025.pdf
6. Virginia Council of Nurse Practitioners. (2024). HB 971 legislative update: Autonomous practice eligibility reduced to three years. https://www.vcnp.net/advocacy/
7. Virginia Law Library. (2024). Code of Virginia § 54.1-2957: Licensure and practice of advanced practice registered nurses. https://law.lis.virginia.gov/vacode/54.1-2957/
8. Virginia Law Library. (2024). Code of Virginia § 54.1-2957.01: Prescription of certain controlled substances and devices by licensed advanced practice registered nurses. https://law.lis.virginia.gov/vacode/54.1-2957.01/

Compose a 500–750 word APA discussion post analyzing Virginia APRN prescriptive authority, collaborative practice agreements under HB 971, controlled substance prescribing, and interprofessional rash management across the lifespan.

Write a 2–3 page discussion analyzing Virginia’s nurse practice act requirements for APRN collaborative agreements, prescribing authority, and dermatological scope of practice with peer-reviewed citations.

Next Week Assignment Preview

Week 3 Assignment: Pharmacotherapeutic Management of Common Infections

For Week 3, you will complete a Case Study Analysis (750–1,000 words) addressing the pharmacological management of upper respiratory infections, urinary tract infections, and skin and soft tissue infections across the lifespan. The assignment requires you to select one case scenario from a provided list, develop a complete treatment plan including first-line and alternative pharmacotherapy, address patient education points, and discuss antibiotic stewardship principles. You must integrate at least three peer-reviewed sources and follow APA 7th edition formatting. The grading rubric will emphasize diagnostic reasoning, appropriate antibiotic selection, patient safety considerations (including allergy assessment and drug interactions), and evidence-based patient education strategies. This assignment builds directly on the regulatory foundations established in Week 2 by requiring you to apply Virginia’s prescriptive authority framework to actual clinical decision-making.

The post HB 971 and Nurse Practitioner Autonomous Practice in Virginia appeared first on EssayBishops.